ZA796918B - Pharmaceutical composition for treating neoplastic diseases and methods of preparation - Google Patents
Pharmaceutical composition for treating neoplastic diseases and methods of preparationInfo
- Publication number
- ZA796918B ZA796918B ZA00796918A ZA796918A ZA796918B ZA 796918 B ZA796918 B ZA 796918B ZA 00796918 A ZA00796918 A ZA 00796918A ZA 796918 A ZA796918 A ZA 796918A ZA 796918 B ZA796918 B ZA 796918B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparation
- methods
- pharmaceutical composition
- neoplastic diseases
- treating neoplastic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/971,729 US4384001A (en) | 1978-12-21 | 1978-12-21 | Treatment of tumors with thiazolidine-4-carboxylic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA796918B true ZA796918B (en) | 1980-11-26 |
Family
ID=25518727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA00796918A ZA796918B (en) | 1978-12-21 | 1979-12-20 | Pharmaceutical composition for treating neoplastic diseases and methods of preparation |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4384001A (fr) |
| JP (1) | JPS55115822A (fr) |
| AU (1) | AU5390579A (fr) |
| BE (1) | BE880744A (fr) |
| CA (1) | CA1149284A (fr) |
| DE (1) | DE2951050A1 (fr) |
| DK (1) | DK542979A (fr) |
| ES (1) | ES487052A0 (fr) |
| FR (1) | FR2444459A1 (fr) |
| GB (1) | GB2039736B (fr) |
| IL (1) | IL58948A0 (fr) |
| IT (1) | IT1193348B (fr) |
| LU (1) | LU82013A1 (fr) |
| NL (1) | NL7909199A (fr) |
| SE (1) | SE7910300L (fr) |
| ZA (1) | ZA796918B (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE53332B1 (en) * | 1980-03-14 | 1988-10-26 | Efamol Ltd | Pharmaceutical compositions |
| JPS57128625A (en) * | 1981-01-30 | 1982-08-10 | Rikagaku Kenkyusho | Carcinostatic |
| US4335210A (en) * | 1981-02-11 | 1982-06-15 | Cornell Research Foundation | Method of producing L-cysteine |
| FR2547728B1 (fr) * | 1983-06-24 | 1986-05-02 | Riker Laboratories Inc | Medicament a base d'acide d thiazolidine carboxylique |
| FR2547729B1 (fr) * | 1983-06-24 | 1986-05-02 | Riker Laboratories Inc | Medicament a base d'acide dl thiazolidine carboxylique |
| JPS62501769A (ja) * | 1984-12-18 | 1987-07-16 | デイビツト ラビン | 細胞毒性アルデヒドとベニシラミンとの反応性成物を含有する抗腫瘍組成物及びその使用方法 |
| JPH066578B2 (ja) * | 1985-12-27 | 1994-01-26 | 三共株式会社 | チアゾリジン誘導体 |
| JPH01170063U (fr) * | 1988-05-11 | 1989-11-30 | ||
| JPH0467539U (fr) * | 1990-10-18 | 1992-06-16 | ||
| DE69214467T3 (de) * | 1991-01-10 | 2000-09-28 | Transcend Therapeutics Inc | Verwendung von L-2-oxo Thiazolidin-4-carboxylat zur Behandlung von Atemnotsyndrom |
| ES2277787B1 (es) * | 2006-01-02 | 2008-06-16 | Universidad De Cadiz | Empleo de tioprolina en tratamientos de reduccion de peso corporal. |
-
1978
- 1978-12-21 US US05/971,729 patent/US4384001A/en not_active Expired - Lifetime
-
1979
- 1979-12-12 GB GB7942753A patent/GB2039736B/en not_active Expired
- 1979-12-13 IL IL58948A patent/IL58948A0/xx unknown
- 1979-12-14 SE SE7910300A patent/SE7910300L/xx unknown
- 1979-12-17 AU AU53905/79A patent/AU5390579A/en not_active Abandoned
- 1979-12-18 IT IT28170/79A patent/IT1193348B/it active
- 1979-12-19 DE DE19792951050 patent/DE2951050A1/de not_active Withdrawn
- 1979-12-19 LU LU82013A patent/LU82013A1/fr unknown
- 1979-12-19 BE BE0/198657A patent/BE880744A/fr not_active IP Right Cessation
- 1979-12-19 FR FR7931158A patent/FR2444459A1/fr active Granted
- 1979-12-19 CA CA000342263A patent/CA1149284A/fr not_active Expired
- 1979-12-19 ES ES487052A patent/ES487052A0/es active Granted
- 1979-12-19 DK DK542979A patent/DK542979A/da unknown
- 1979-12-20 JP JP16495079A patent/JPS55115822A/ja active Granted
- 1979-12-20 ZA ZA00796918A patent/ZA796918B/xx unknown
- 1979-12-20 NL NL7909199A patent/NL7909199A/nl not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2444459B1 (fr) | 1983-04-01 |
| NL7909199A (nl) | 1980-06-24 |
| BE880744A (fr) | 1980-06-19 |
| FR2444459A1 (fr) | 1980-07-18 |
| SE7910300L (sv) | 1980-06-22 |
| GB2039736B (en) | 1983-04-13 |
| AU5390579A (en) | 1980-06-26 |
| DE2951050A1 (de) | 1980-07-10 |
| IL58948A0 (en) | 1980-03-31 |
| IT1193348B (it) | 1988-06-15 |
| CA1149284A (fr) | 1983-07-05 |
| US4384001A (en) | 1983-05-17 |
| ES8102108A1 (es) | 1980-12-16 |
| IT7928170A0 (it) | 1979-12-18 |
| ES487052A0 (es) | 1980-12-16 |
| JPS55115822A (en) | 1980-09-06 |
| JPS6328045B2 (fr) | 1988-06-07 |
| DK542979A (da) | 1980-06-22 |
| GB2039736A (en) | 1980-08-20 |
| LU82013A1 (fr) | 1981-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2013495A (en) | Therapeutic method for the treatment of hyperlipodaemias and hyperlipoproteinaemias | |
| JPS54119025A (en) | Tickening of cosmetic * pharmaceutical and technical preparation | |
| GB2029218B (en) | Pharmaceutical composition for treatment of cardiovascular disease | |
| GB2028826B (en) | Acyl-derivatives of carnitine and process for their preparation | |
| JPS54113442A (en) | Treating agent of hyperlipoid disease | |
| GB2086390B (en) | 1-carboxy-azaalkanoylindoline-2-carboxylic acids process for their manufacture pharmaceutical preparations containing these compounds and their therapeutic application | |
| ZA79575B (en) | 1-aryloxy 3-nitratoalkylamino 2-propanols and process for their preparation | |
| ZA79264B (en) | 2h-benzofuran-3-one-derivatives and process for their preparation | |
| ZA796918B (en) | Pharmaceutical composition for treating neoplastic diseases and methods of preparation | |
| HU179689B (en) | Pharmaceutical composition against psoriasis and process for preparing such composition | |
| GB2019837B (en) | N - oxacyclic - alkylpiperidyl - diaza compounds process for their manufacture and pharmaceutical compositions contaaining them | |
| PT73061B (en) | Process for the preparation of new derivatives of taurina and its pharmaceutical use | |
| IL56895A0 (en) | Phenoxyalkylamines and process for their preparation | |
| GB2030294B (en) | Composition for determination of human b-microglobulin process for its preparation and its use | |
| GB2030293B (en) | Composition for determination of human immunoglobulin g process for its preparation and its use | |
| GB2022998B (en) | Phermaceutical composition for the treatment of neoplasticand other diseases | |
| GB2038802B (en) | Aryltrifluoroethanols process for their preparation and pharmaceutical compositions containing them | |
| JPS539757A (en) | Production of taunorbicine derivatives and pharmaceutical composition for treating tumor of human | |
| PT70556A (en) | Vaccines against diseases caused by reo-virus and process for the preparation of those vaccines | |
| GB2076399B (en) | Process for the manufacture of novel benzazole derivatives pharmaceutical preparations containing these derivatives and their use | |
| CY1290A (en) | Azathianaphthalene derivatives process for their manufacture pharmaceutical preparations containing them and their use | |
| DE3065252D1 (en) | Medicinal preparation for the treatment of carcinoma and process for preparing it | |
| AU4717679A (en) | Herbal cream for treatment of diseases | |
| ZA795895B (en) | Ravidomycin and process of preparation | |
| ZA79449B (en) | Therapeutic method for the treatment of hyperlipoproteinaemias and hyperlipodaemias |